Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response
admin A flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday,…
Read Moregsk
China eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a day
China counted more than 10,000 fresh COVID cases on Friday sparking further restrictions on movement,…
Read MoreChina eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a day
China counted more than 10,000 fresh COVID cases on Friday sparking further restrictions on movement,…
Read MoreGSK Says Dreamm-3 Phase 3 Study For Blenrep Didn’t Meet Primary Endpoint
By Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients…
Read MoreGSK lifts 2022 view after third quarter sales of $8.99 billion beat forecasts
GSK PLC on Wednesday raised its guidance for the full year and posted rising sales…
Read MoreGSK respiratory syncytial virus vaccine Phase 3 trial meets primary endpoint
GSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine…
Read MoreGSK says U.S. FDA approves Boostrix for immunization during pregnancy
GSK PLC GSK, -0.10% said Monday that the U.S. Food and Drug Administration has approved…
Read MoreSpero’s stock jumps 188% after GSK licenses experimental antibiotic
Shares of Spero Therapeutics Inc. SPRO, +204.20% soared 188.4% in trading on Thursday morning after…
Read MoreGSK defends Zantac ahead of trials that have cratered the stock
GSK on Friday put out a statement saying there’s no link between a withdrawn heartburn…
Read MoreU.S. stocks end mixed as rally tied to cooler inflation data takes breather
U.S. stocks ended mostly lower on Thursday, despite hitting a three-month high early in the…
Read More